Show Search Form
human indexable | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||||
registered interest | |||||||||||||||||
answer date | |||||||||||||||||
date | |||||||||||||||||
date tabled | |||||||||||||||||
ddp created | |||||||||||||||||
answering body |
|
||||||||||||||||
question status | Tabled | ||||||||||||||||
answering dept id | 11 | ||||||||||||||||
answering dept short name | Defence | ||||||||||||||||
answering dept sort name | Defence | ||||||||||||||||
ddp modified |
|
||||||||||||||||
hansard heading | Armed Forces: Mefloquine | ||||||||||||||||
house id | 2 | ||||||||||||||||
identifier | HL17221 | ||||||||||||||||
legislature |
|
||||||||||||||||
parliament number | 57 | ||||||||||||||||
question first answered |
|
||||||||||||||||
question text | To ask Her Majesty's Government, further to the Written Answer by Baroness Blackwood of North Oxford on 10 July (HL16834), what steps the Ministry of Defence has taken to address the concerns of the European Medicines Agency Pharmacovigilance Assessment Committee 2014 report on the toxicity of mefloquine (Lariam); and if they have not taken any such steps, why not. | ||||||||||||||||
session |
|
||||||||||||||||
session number | 1 | ||||||||||||||||
tabling member printed |
|
||||||||||||||||
title | House of Lords Tabled Parliamentary Question 2017/19 HL17221 | ||||||||||||||||
type |
|
||||||||||||||||
uin | HL17221 | ||||||||||||||||
version | 1 | ||||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||||
answer |
|
||||||||||||||||
creator |
|
||||||||||||||||
publisher |
|
||||||||||||||||
tabling member |
|